Abstract
Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2u8I4ap
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου